Home > Balance Sheet > NEULAND LABORATORIES

NEULAND LABORATORIES
Contingent Liabilities

    Back to Balance Sheet
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹83 Cr₹91 Cr₹75 Cr₹105 Cr₹125 Cr

What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?

The latest Contingent Liabilities ratio of NEULAND LABORATORIES is ₹83 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹83 Cr
Mar2023₹91 Cr
Mar2022₹75 Cr
Mar2021₹105 Cr
Mar2020₹125 Cr

How is Contingent Liabilities of NEULAND LABORATORIES Trending?

Years Contingent Liabilities % Change
Mar2024 ₹83 Cr
-9.48
Mar2023 ₹91 Cr
22.14
Mar2022 ₹75 Cr
-28.68
Mar2021 ₹105 Cr
-16.46
Mar2020 ₹125 Cr -

Compare Contingent Liabilities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,358.5 Cr -0.1% 2.1% 52.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,284.0 Cr -0% -0.4% 10.2% Stock Analytics
DIVIS LABORATORIES ₹183,268.0 Cr 1.4% 4.1% 50.3% Stock Analytics
CIPLA ₹122,253.0 Cr 0.5% 1.6% 1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,988.0 Cr -1.2% 7.1% 18.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr 1.7% 1.2% 1.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-0.1%

2.1%

52.7%

SENSEX

-0.7%

3%

5%


You may also like the below Video Courses